News

Galectin's belapectin shows promise in MASH cirrhosis despite setbacks. High-risk investment with upcoming FDA meeting ...
Serious infections significantly increase the mortality risk among adults with chronic liver disease, including those without cirrhosis.
Low blood sugar (hypoglycaemia) can occur even without diabetes. Learn about its causes, symptoms, risks, and when to seek ...
The National Health Service (NHS) in the UK has expanded its community liver health check programme through scanning trucks, ...
States along the Gulf Coast have raised alarms about a rise in infections from flesh-eating bacteria. In Louisiana, doctors ...
Thousands more people in England have been referred for liver cancer checks thanks to the expansion of an NHS scheme that ...
Learn about the use of GLP-1 agonists for weight loss and health improvement by celebrities like Oprah and Serena Williams.
Wegovy is now approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosis.
A married couple in Pune dies days apart following liver transplant surgery, prompting official investigation into medical ...
Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a fast-growing biopharmaceutical company committed to improving patient lives ...